Byotrol PLC Capital Reorganisation Delay

RNS Number : 5690L

Byotrol PLC

22 April 2024

 

 

 

Byotrol Plc

("Byotrol" or the "Company")

 

Capital Reorganisation Delay

 

Byotrol Plc (AIM: BYOT), the specialist infection prevention and control company, announces that owing to an administrative error the Company's Capital Reorganisation as previously announced will no longer become effective at the close of business today but instead at the close of business on 24 April 2024.

 

The Company confirms that the cancellation of admission of the Company's ordinary shares to trading on AIM remains effective at 7.00 a.m. on 30 April 2024. The Company will re-register as a private limited company with the name Byotrol Limited which is expected to take by 21 May 2024.

 

Unless otherwise indicated, defined terms in this announcement shall have the same meaning as described in the Circular.

 

 

For further information contact:

 

Byotrol Plc
Dr Trevor Francis, Non- Executive Chairman	[phone]
David Traynor, Interim Chief Executive Officer Chris Sedwell, Chief Financial Officer
Cavendish Capital Markets Limited (Nominated Adviser and Broker)	[phone]
Geoff Nash/George Dollemore - Corporate Finance Nigel Birks/Harriet Ward - ECM
Flagstaff Strategic and Investor Communications	[phone]
Tim Thompson/Andrea Seymour/Fergus Mellon	[e-mail]

 

 

 

 

 

Notes to editors

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the animal and human healthare, industrial, institutional and consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

 

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

 

For more information, go to byotrol.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

CAREASLAALALEFA